NIH Director's New Innovator Award (DP2 Clinical Trial Optional)
Forecast
National Institutes of Health plans to offer grants of up to $475,000 (at least $475,000) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expects to make about 30 awards worth $22.7 million in total. It is a forecast: the notice is expected around March 15, 2027, with applications due around August 19, 2027.
From the official notice on Grants.gov, last changed September 3, 2026. Checked October 31, 2026.
- Award ceiling$475,000
- Award floor$475,000
- Expected awards30
- Total funding$22.7 million
- Cost sharingNot required
- Funding typeGrant
Key dates
| Forecast posted | September 3, 2026 |
|---|---|
| Expected posting | March 15, 2027 |
| Expected deadline | August 19, 2027 |
| Expected award date | August 30, 2028 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The NIH Director's New Innovator Award supports exceptionally creative early-stage investigators pursuing bold, innovative research with the potential to transform important areas of science relevant to the NIH mission. Applications are welcome across all fields relevant to NIH. The award complements other NIH programs that support early-stage investigators and is part of the NIH Common Fund's High-Risk, High-Reward Research Program.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to NIH Director's New Innovator Award Program, NewInnovatorAwards@mail.nih.gov, Please contact via e-mail..
Questions people ask
Who can apply for NIH Director's New Innovator Award (DP2 Clinical Trial Optional)?
National Institutes of Health accepts applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for NIH Director's New Innovator Award (DP2 Clinical Trial Optional)?
Expected deadline August 19, 2027. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $475,000 each. About $22.7 million in total across about 30 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience